SILANES Trademark

Trademark Overview


On Tuesday, May 22, 2012, a trademark application was filed for SILANES with the United States Patent and Trademark Office. The USPTO has given the SILANES trademark a serial number of 85632415. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 23, 2021. This trademark is owned by Laboratorios Silanes S.A. DE C.V.. The SILANES trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, injectable solutions, tablets, pills and capsules for adults and children, oral suspensions, medicated syrups and ointments, all for treatment as a cough suppressant, and expectorant, having activity against anaerobic bacteria, trichomona vaginalis, entamoeba histolytica, and giardia lamblia, as an antifungal agent for treatment of oropharyngeal and esophageal candidiasis, candidal urinary tract infections, peritonitis and systemic candidal infections, candidemia, disseminated candidiasis and pneumonia, cryptococcal meningitis, candidal genital tract infections, as an analgesis anti-inflamatory non steroidal inhibitor of prostaglandin synthetase, analgesic and minor tranquilizer, active immunization against tetanus, peripheral neuritis, neuralgias, peripheral neuritis, neuralgias and haematopoietics, antifungal agents for treatment of systemic blastomycosis, histoplasmosis paracoccidloidomycosis, fungal infection of the gastrointestinal tract and tinea infectio...
silanes

General Information


Serial Number85632415
Word MarkSILANES
Filing DateTuesday, May 22, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 23, 2021
Registration Number4654888
Registration DateTuesday, December 16, 2014
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 13, 2014

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of the term "SILANES" on a wire globe, surrounded by two arching bars spanning the front of the globe.
Goods and ServicesPharmaceuticals, namely, injectable solutions, tablets, pills and capsules for adults and children, oral suspensions, medicated syrups and ointments, all for treatment as a cough suppressant, and expectorant, having activity against anaerobic bacteria, trichomona vaginalis, entamoeba histolytica, and giardia lamblia, as an antifungal agent for treatment of oropharyngeal and esophageal candidiasis, candidal urinary tract infections, peritonitis and systemic candidal infections, candidemia, disseminated candidiasis and pneumonia, cryptococcal meningitis, candidal genital tract infections, as an analgesis anti-inflamatory non steroidal inhibitor of prostaglandin synthetase, analgesic and minor tranquilizer, active immunization against tetanus, peripheral neuritis, neuralgias, peripheral neuritis, neuralgias and haematopoietics, antifungal agents for treatment of systemic blastomycosis, histoplasmosis paracoccidloidomycosis, fungal infection of the gastrointestinal tract and tinea infections of the skin and nails, sulphonylurea and biguanide, hipoglycaemic agent, activity against trichomonas vaginalis, entamoeba histolytica and giardia lamblia, anaerobic bacteria, histamine h1-receptor antagonist and prophylactic treatment of asthma, and treatment of allergic conditions such as rhinitis and conjunctivitis, analgesic, anti-inflamatory non steroidal, for inhibiting prostaglandin synthetase, analgesic, anti-inflammatory non steroidal, inhibitor of prostaglandin synthetase and muscle relaxant, analgesic, antipyretic, sulphonylurea hipoglycaemic agent, for inhibiting as an angiotensin-converting enzyme, treatment of congestive heart failure and asymptomatic left ventricular dysfunction, diuretic treatment of congestive heart failure, hypertension, cardiac, renal hepatogenic oedema, peripheral neuritis, neuralgias and analgesic, a broad spectrum antibiotic, effective against a wide range of gram positive and gram negative aerobic and anaerobic bacterias, histamine h2-receptor antagonist in the treatment of gastric and duodenal ulcer, zollinger-ellison syndrome, for iron deficiency and anemia for children or adults, anixolytic , anticonvulsant, sedative, muscle relaxant, histamine h2-receptor antagonist in the treatment of gastric and duodenal ulcer zollinger-ellison syndrome, multivitamin treatment and prevention of vitamin b1-b6-b12 deficiency, tricyclic antidepressant, treatment of nocturnal enuresis in children, inhibition of angiotensin-converting enzyme, treatment of hypertension and congestive heart failure, treatment and prevention of vitamin C deficiency, treatment and prevention of seborrhea and dandruff, and as an analgesic not narcotic
Section 2(f) Limitation Statementas to "SILANES"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 23, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLaboratorios Silanes S.A. DE C.V.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMexico DF CP03100
MX

Party NameLaboratorios Silanes S.A. DE C.V.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMexico DF CP03100
MX

Party NameLaboratorios Silanes S.A. DE C.V.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMexico DF CP03100
MX

Trademark Events


Event DateEvent Description
Friday, July 23, 2021CANCELLED SEC. 8 (6-YR)
Monday, December 16, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, December 16, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, September 9, 20141(B) BASIS DELETED; PROCEED TO REGISTRATION
Sunday, August 24, 2014NOTICE OF ALLOWANCE CANCELLED
Friday, August 29, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sunday, August 24, 2014TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, July 8, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 13, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 13, 2014PUBLISHED FOR OPPOSITION
Wednesday, April 23, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 9, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, April 8, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 8, 2014DATA MODIFICATION COMPLETED
Monday, April 7, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 7, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, March 30, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 22, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 22, 2013NON-FINAL ACTION E-MAILED
Friday, November 22, 2013NON-FINAL ACTION WRITTEN
Thursday, October 31, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 30, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 30, 2013TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, October 30, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 17, 2013NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, July 17, 2013LETTER OF SUSPENSION E-MAILED
Wednesday, July 17, 2013SUSPENSION LETTER WRITTEN
Friday, June 7, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 7, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 30, 2013ASSIGNED TO LIE
Tuesday, May 28, 2013NOTICE OF REVIVAL - E-MAILED
Monday, May 27, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 27, 2013PETITION TO REVIVE-GRANTED
Monday, May 27, 2013TEAS PETITION TO REVIVE RECEIVED
Wednesday, April 17, 2013ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, April 17, 2013ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, September 19, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 19, 2012NON-FINAL ACTION E-MAILED
Wednesday, September 19, 2012NON-FINAL ACTION WRITTEN
Tuesday, September 11, 2012ASSIGNED TO EXAMINER
Thursday, May 31, 2012NOTICE OF DESIGN SEARCH CODE MAILED
Wednesday, May 30, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, May 25, 2012NEW APPLICATION ENTERED IN TRAM